Healthcare provider profile · identity verified

Radha K.C., M.D.

Internal Medicine · NORFOLK, VA · NPI 1215280359

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	644	198
Amlodipine Besylate	Amlodipine Besylate	520	159
Losartan Potassium	Losartan Potassium	489	150
Simvastatin	Simvastatin	438	132
Levothyroxine Sodium	Levothyroxine Sodium	377	103
Omeprazole	Omeprazole	334	96
Lisinopril	Lisinopril	280	81
Metformin Hcl	Metformin Hcl	245	77
Furosemide	Furosemide	222	79
Metoprolol Succinate	Metoprolol Succinate	220	66
Hydrochlorothiazide	Hydrochlorothiazide	211	67
Albuterol Sulfate Hfa	Albuterol Sulfate	188	64
Rosuvastatin Calcium	Rosuvastatin Calcium	162	61
Sertraline Hcl	Sertraline Hcl	158	39
Ezetimibe	Ezetimibe	155	50
Eliquis	Apixaban	154	35
Metoprolol Tartrate	Metoprolol Tartrate	153	49
Carvedilol	Carvedilol	148	43
Montelukast Sodium	Montelukast Sodium	130	39
Metformin Hcl Er	Metformin Hcl	125	44
Pantoprazole Sodium	Pantoprazole Sodium	112	32
Clopidogrel	Clopidogrel Bisulfate	111	38
Gabapentin	Gabapentin	111	34
Pravastatin Sodium	Pravastatin Sodium	100	30
Fluticasone Propionate	Fluticasone Propionate	99	42
Tamsulosin Hcl	Tamsulosin Hcl	99	34
Trazodone Hcl	Trazodone Hcl	96	36
Zolpidem Tartrate	Zolpidem Tartrate	95	28
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	83	28
Alprazolam	Alprazolam	80	28
Atenolol	Atenolol	76	21
Glipizide	Glipizide	74	21
Mirtazapine	Mirtazapine	71	22
Hydralazine Hcl	Hydralazine Hcl	70	19
Spironolactone	Spironolactone	68	25
Famotidine	Famotidine	60	20
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	60	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	16
Fluconazole	Fluconazole	57	23
Clonazepam	Clonazepam	55	17
Nifedipine Er	Nifedipine	55	13
Synthroid	Levothyroxine Sodium	54	23
Vitamin D2	Ergocalciferol (Vitamin D2)	54	16
Xarelto	Rivaroxaban	53	suppressed
Glimepiride	Glimepiride	51	18
Ibuprofen	Ibuprofen	50	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	18
Potassium Chloride	Potassium Chloride	48	18
Venlafaxine Hcl Er	Venlafaxine Hcl	46	12
Citalopram Hbr	Citalopram Hydrobromide	45	12
Duloxetine Hcl	Duloxetine Hcl	45	11
Tramadol Hcl	Tramadol Hcl	45	13
Chlorthalidone	Chlorthalidone	44	11
Fluoxetine Hcl	Fluoxetine Hcl	44	14
Tizanidine Hcl	Tizanidine Hcl	44	11
Triamcinolone Acetonide	Triamcinolone Acetonide	41	22
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	38	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	37	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	37	15
Januvia	Sitagliptin Phosphate	37	suppressed
Donepezil Hcl	Donepezil Hcl	35	suppressed
Jardiance	Empagliflozin	35	suppressed
Ramipril	Ramipril	35	suppressed
Warfarin Sodium	Warfarin Sodium	35	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	33	suppressed
Lorazepam	Lorazepam	33	11
Bupropion Xl	Bupropion Hcl	32	suppressed
Finasteride	Finasteride	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	11
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Valacyclovir	Valacyclovir Hcl	31	15
Bumetanide	Bumetanide	30	suppressed
Hydrocortisone	Hydrocortisone	30	12
Nystatin	Nystatin	30	11
Ondansetron Odt	Ondansetron	30	15
Ropinirole Hcl	Ropinirole Hcl	30	suppressed
Baclofen	Baclofen	29	12
Ketoconazole	Ketoconazole	29	suppressed
Allopurinol	Allopurinol	28	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Levetiracetam	Levetiracetam	28	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	26	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Celecoxib	Celecoxib	24	suppressed
Clonidine Hcl	Clonidine Hcl	24	suppressed
Ozempic	Semaglutide	23	suppressed
Verapamil Er	Verapamil Hcl	22	suppressed
Meclizine Hcl	Meclizine Hcl	21	suppressed
Naproxen	Naproxen	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Flecainide Acetate	Flecainide Acetate	20	suppressed
Telmisartan	Telmisartan	20	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	20	suppressed
Clotrimazole	Clotrimazole	19	12
Lovastatin	Lovastatin	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	11
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Valsartan	Valsartan	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	14
Glipizide Er	Glipizide	17	suppressed
Lidocaine	Lidocaine	17	suppressed
Temazepam	Temazepam	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Azithromycin	Azithromycin	16	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	12
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Linzess	Linaclotide	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	11
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Prednisone	Prednisone	15	suppressed
Dexlansoprazole Dr	Dexlansoprazole	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Verapamil Sr	Verapamil Hcl	14	suppressed
Meloxicam	Meloxicam	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Benzonatate	Benzonatate	12	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Estradiol	Estradiol	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error